US representatives are pressing genetic testing companies for details on their security systems and customer privacy policies.
A comprehensive analysis of published research, suggests that there is not enough evidence to claim genetic links to dietary recommendations.
Researchers at the University of Oulu in Finland have discovered novel genes and mechanisms that can explain how a genomic variant in a single nucleotide polymorphism (SNP) rs11672691 influences prostate cancer aggressiveness.
The strengths of blockchain technologies could help address the weaknesses of health care systems to store and secure medical records.
Genome research suggests that enteric fever, a potentially lethal disease more commonly found in hot countries, was present in medieval Europe.
Scientists have mapped 41 genes that increase the risk of developing hay fever, in a new study of almost 900,000 people. Of the genes, 20 are new to science.
ASHG announces 4 scientists they intend to honour with awards at their Annual Meeting in October: Jan M. Friedman, Mary-Claire King, Cecilia Lindgren, and Sekar Kathiresan.
MPs vote 305-301 that the UK should negotiate to remain part of the European Medicines Agency following Brexit, sending “a clear message that patients and public health should be a top priority”.
Billionaire philanthropist Bill Gates has donated $30 million towards incentivising the development of an Alzheimer’s diagnostic test.
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice.
Scientists have previously overlooked the astonishing physical strength of the thin outer membrane that clings to E. coli‘s stout cell wall, according to a new study.
Clinical trials involving probiotics are failing to report on the safety and harms of these treatments.
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, new findings suggest.
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumour suppressor.
Presage Biosciences has announced that they have received a $6 million investment from Takeda and Celgene, as well as appointing a new Chief Executive Officer.